Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
2,672,544
-
Share change
-
-312,962,534
-
Total reported value
-
$78,738,323
-
Price per share
-
$29.43
-
Number of holders
-
31
-
Value change
-
-$13,603,554,693
-
Number of buys
-
7
-
Number of sells
-
798
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q3 2022
As of 30 Sep 2022,
GLAXOSMITHKLINE PLC - ADR (GSK) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,672,544 shares.
The largest 10 holders included
KAHN BROTHERS GROUP INC, Tri Locum Partners LP, Keystone Financial Planning, Inc., Tweedy, Browne Co LLC, HOURGLASS CAPITAL, LLC, MACQUARIE GROUP LTD, ADVISORS MANAGEMENT GROUP INC /ADV, Old Port Advisors, Knott David M Jr, and Elevated Capital Advisors, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.